Fortress Biotech to Present at September 2019 Investor Conferences

NEXT STORY
Oasmia publishes its annual report and adjusts accounts due to write-downs – auditors do not recommend former board to be granted discharge from liability
PREV STORY
American BriVision Announces Strategic Collaboration with BioLite Japan
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Gilead and Vir Biotechnology Establish Clinical Collaboration to Explore Combination Strategies for Functional Cure for Chronic Hepatitis B Virus

author_avatar
NASDAQ Market News

Pfizer and BioNTech to Supply the United States with 100 Million Additional Doses of COVID-19 Vaccine

author_avatar
NASDAQ Market News

Antibiotics Market Expected to Garner $50.37 Bn by 2025 at 2.1% CAGR, Says AMR

author_avatar
NASDAQ Market News